HALO — HALOZYME THERAPEUTICS INC

Ownership history in EntryPoint Capital, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in HALOZYME THERAPEUTICS INC (HALO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.23% (2025 Q1)
Avg. % of fund
0.15%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 4,148 -3,758 -47.5% 0.12% $304K $73.34
2025 Q1 ADDED 7,906 +3,094 +64.3% 0.23% $504K $63.81
2024 Q4 INITIATED 4,812 — — 0.10% $230K $47.81
% of Fund (quarterly)    HALO price (monthly, adj. close)

Other funds also holding HALO

As of 2025 Q4 — sorted by position size

Koa Wealth Management, LLC 4.3% SNYDER CAPITAL MANAGEMENT L P 3Y 7Y 3.01% Steamboat Capital Partners, LLC 3Y 7Y 2.66% South Street Advisors LLC 3Y 7Y 2.19% BERNZOTT CAPITAL ADVISORS 3Y 7Y 2.17% 2Xideas AG 3Y 1.98% Future Fund LLC 3Y 1.77% MIZUHO MARKETS AMERICAS LLC 3Y 1.65% Verity Asset Management, Inc. 3Y 7Y 1.53% RENAISSANCE GROUP LLC 3Y 7Y 1.3%
← Back to EntryPoint Capital, LLC Holdings